Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali.
Autor: | Mahamar A; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Issiaka D; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Barry A; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Attaher O; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Dembele AB; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Traore T; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Sissoko A; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Keita S; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Diarra BS; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Narum DL; Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH, 12735 Twinbrook Pkway Building TW3 Room 3W15, Rockville, MD, 20852, USA., Duffy PE; Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH, 12735 Twinbrook Pkway Building TW3 Room 3W15, Rockville, MD, 20852, USA., Dicko A; Malaria Research & Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Fried M; Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH, 12735 Twinbrook Pkway Building TW3 Room 3W15, Rockville, MD, 20852, USA. michal.fried@nih.gov. |
---|---|
Jazyk: | angličtina |
Zdroj: | Malaria journal [Malar J] 2017 Jul 18; Vol. 16 (1), pp. 289. Date of Electronic Publication: 2017 Jul 18. |
DOI: | 10.1186/s12936-017-1935-4 |
Abstrakt: | Background: Seasonal malaria chemoprevention (SMC) is a new strategy to reduce malaria burden in young children in Sahelian countries. It consists of the administration of full treatment courses of sulfadoxine-pyrimethamine plus amodiaquine to children at monthly intervals during the malaria season. However, it is not clear if there is a cumulative effect of SMC over time on acquisition of antibodies to malaria antigens. Methods: A cross-sectional serosurvey was carried out 1 month after the last dose of SMC in 2016. Children aged 3-4 years were randomly selected from areas where SMC was given for 1, 2 or 3 years during the malaria season. Children in the areas where SMC had been implemented for 1 year but who failed to receive SMC were used as comparison group. Antibody extracted from dry blood spots was used to measure IgG levels to CSP, MSP-1 Results: The prevalence of antibodies to AMA-1 were high and similar in children who received SMC for 1, 2 or 3 years and also when compared to those who never received SMC (96.3 vs 97.5%, adjusted OR = 0.99, 95% CI 0.33-2.97, p = 0.99). The prevalence of antibodies to MSP-1 Conclusions: SMC reduced seropositivity to MSP-1 |
Databáze: | MEDLINE |
Externí odkaz: |